244 related articles for article (PubMed ID: 17508172)
1. Recent advances in the pharmacogenomics of pain and headache.
Montagna P
Neurol Sci; 2007 May; 28 Suppl 2():S208-12. PubMed ID: 17508172
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors in pain and its treatment.
Stamer UM; Stüber F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
[TBL] [Abstract][Full Text] [Related]
3. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
Adegbola MA
Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
[TBL] [Abstract][Full Text] [Related]
4. Genetics of pain, opioids, and opioid responsiveness.
Tremblay J; Hamet P
Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195
[TBL] [Abstract][Full Text] [Related]
5. Understanding the genetic determinants of pain and pain management.
Miaskowski C
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in pain management: the clinical need.
Webster LR
Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
[TBL] [Abstract][Full Text] [Related]
7. Genetics. Unraveling pain's DNA.
Couzin J
Science; 2006 Oct; 314(5799):585-6. PubMed ID: 17068236
[No Abstract] [Full Text] [Related]
8. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
9. Genetics and variability in opioid response.
Stamer UM; Bayerer B; Stüber F
Eur J Pain; 2005 Apr; 9(2):101-4. PubMed ID: 15737794
[TBL] [Abstract][Full Text] [Related]
10. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
11. [An update on the familial headache syndromes].
Takeshima T; Kusumi M; Fukuhara Y; Kowa H; Adachi Y; Nakashima K
Rinsho Shinkeigaku; 2004 Nov; 44(11):944-7. PubMed ID: 15651339
[TBL] [Abstract][Full Text] [Related]
12. Two novel SCN9A mutations causing insensitivity to pain.
Nilsen KB; Nicholas AK; Woods CG; Mellgren SI; Nebuchennykh M; Aasly J
Pain; 2009 May; 143(1-2):155-8. PubMed ID: 19304393
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutations that prevent pain: implications for future pain medication.
Oertel B; Lötsch J
Pharmacogenomics; 2008 Feb; 9(2):179-94. PubMed ID: 18370847
[TBL] [Abstract][Full Text] [Related]
14. Implications of pharmacogenomics for anesthesia providers.
Ama T; Bounmythavong S; Blaze J; Weismann M; Marienau MS; Nicholson WT
AANA J; 2010 Oct; 78(5):393-9. PubMed ID: 21067087
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
16. Opioid genetics: the key to personalized pain control?
Branford R; Droney J; Ross JR
Clin Genet; 2012 Oct; 82(4):301-10. PubMed ID: 22780883
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphisms and opioid therapies].
Landau R
Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
[TBL] [Abstract][Full Text] [Related]
18. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
19. Genetics of chronic pain states.
Buskila D
Best Pract Res Clin Rheumatol; 2007 Jun; 21(3):535-47. PubMed ID: 17602998
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and migraine: possible implications.
Tfelt-Hansen P; Brøsen K
J Headache Pain; 2008 Feb; 9(1):13-8. PubMed ID: 18217199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
